AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03459937 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hatha Yoga Intervention
Description: Hatha Yoga will focus on a restorative style of Hatha yoga. Total duration will begin at 100 minutes per week and will gradually progress in 4-week intervals until achieving the prescribed dose of 300 min/wk (5 days per week for 60 minutes per day). While attending the behavioral group sessions the participants will also engage in a supervised yoga session with a trained yoga instructor. To facilitate the additional 4 days of unsupervised yoga, we will provide yoga videos that mimic the asanas (poses) and flow patterns that are taught in the supervised yoga sessions. The intervention includes prescribed dietary recommendations based on the participants' baseline body weight, and self-monitoring diaries, meal plans, and sample recipes will be provided. Intervention lessons will also include information related to behavior strategies for achieving the recommended calorie and fat intake goals. Participants will also be provided weekly group intervention sessions across the study period.
Study NCT03459937 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Vinyasa Yoga Intervention
Description: Vinyasa Yoga will focus on a more vigorous form of yoga. Total duration will begin at 100 minutes per week and will gradually progress in 4-week intervals until achieving the prescribed dose of 300 min/wk (5 days per week for 60 minutes per day). While attending the behavioral group sessions the participants will also engage in a supervised yoga session with a trained yoga instructor. To facilitate the additional 4 days of unsupervised yoga, we will provide yoga videos that mimic the asanas (poses) and flow patterns that are taught in the supervised yoga sessions. The intervention includes prescribed dietary recommendations based on the participants' baseline body weight, and self-monitoring diaries, meal plans, and sample recipes will be provided. Intervention lessons will also include information related to behavior strategies for achieving the recommended calorie and fat intake goals. Participants will also be provided weekly group intervention sessions across the study period.
Study NCT02295397 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: food
Description: food provocation, skin testing, blood sampling
Study NCT01187862 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: caffeine, efavirenz, losartan, omeprazole, metoprolol, chlorzoxazone and midazolam
Study NCT03824626 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: TEVAR patients
Description: Computed Tomography Angiography (CTA) will be performed using a 16-slice unit before and after intravenous administration of 100 mL of iodinated contrast material. Phase contrast-Magnetic Resonance (pc-MRI) will be performed using a 1.5-T unit with 40-mT/m gradient power and a four-channel cardio-thoracic coil. ECG-triggered, free-breathing through plane, and in-plane pc-MRI sequences will be performed for phase-velocity mapping of aortic and branches flow. Ad hoc processing of preoperative CTAs, based on 3D multiplanar reconstruction, will be performed with 3Mensio Vascular software 8.0® (3Mensio Medical Imaging B.V.), which provides specific functions for automatic measurements.
Study NCT03205475 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Weekly Coaching plus Peer Coaching Phase 2
Description: Continue weekly coaching with senior trainer and add weekly peer coaching from another interventionist in the region who is at high fidelity
Study NCT03205475 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Video Feedback Only Phase 2
Description: Receive video feedback and calls only
Study NCT04278469 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Chemotherapy Drugs, Cancer
Description: Clinical high and genomic low Hormone Receptor-positive early breast cancer patients with or without adjuvant chemotherapy
Study NCT03961464 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: d-cycloserine
Description: Single dose
Study NCT03961464 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Single dose
Study NCT01082653 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: autologous bone marrow-derived stem cells
Description: All patients will receive a unique one-time intrathecal infusion of the cell product suspended in infusion medium.
Study NCT06120478 — intervention group
Intervention type: OTHER
Intervention: observe
Description: observational study
Study NCT00516685 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant Human rEGF-P64K/Montanide Vaccine
Study NCT00705341 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: fluticasone
Description: Inhaled corticosteroid approved for treatment of asthma
Study NCT04438616 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: dome magnetic attachment
Description: * All patients will receive complete denture before implant installation .~* The CBCT examination should be take~* patients received infiltration local anesthesia~* A crestal incision is made using No. 15 c blade .~* Full sequential drilling under copious saline irrigation will be made . insertion of two implant by the contra angle handpiece with special adaptor~* We connect magnetic attachment(dome) on complete denture by pick up procedure at day of implant installation.~* Implant stability will be measured using smart peg /osstell at the day of implant installation and after 2,4,8,12 weeks.~* Patient satisfaction measure
Study NCT02327000 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pregabalin 150mg
Description: GLA5PR GLARS-NF1 tablet 150mg/day(Pregabalin 150mg once a day)
Study NCT02327000 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pregabalin 300mg
Description: GLA5PR GLARS-NF1 tablet 300mg/day(Pregabalin 300mg once a day)
Study NCT02785913 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT02785913 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Taselisib
Description: Given PO
Study NCT03567109 — intervention group
Intervention type: OTHER
Intervention: hand laterality judgment task
Description: participants are asked to identify laterality of the hand presented on the screen
Study NCT04438616 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: flat magnetic attachment
Description: * All patients will receive complete denture before implant installation .~* The CBCT examination should be take~* patients received infiltration local anesthesia.~* A crestal incision is made using No. 15 c blade~* Full sequential drilling under copious saline irrigation will be made as indicated by the company guide lines. insertion of two implant by the contra angle handpiece with special adaptor~* We connect magnetic attachment(flat) on complete denture by pick up procedure at day of implant installation.~* Implant stability will be measured using smart peg /osstell at the day of implant installation and after 2,4,8,12 weeks.~* Patient satisfaction measure in 2 weak and after 12 weak by Denture satisfaction questionnaire
Study NCT00417521 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family-Based Treatment
Study NCT01625442 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Saffron tablet
Description: Saffron tablets 100 mg
Study NCT01625442 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Barberry tablet
Description: Barberry tablets 200 mg
Study NCT01625442 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablets received daily for 45 days
Study NCT03107208 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Glargine
Description: A dose of glargine (Lantus) will be given subcutaneously either early in the management of DKA (study group) or upon resolution of DKA (control group).
Study NCT03107208 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Glargine
Description: A dose of glargine (Lantus) will be given subcutaneously either early in the management of DKA (study group) or upon resolution of DKA (control group).
Study NCT03107208 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Continuous Glucose Monitor (Abbott FreeStyle Libre Pro)
Description: All participants will be asked to wear a continuous glucose monitor (CGM) during the DKA and for a week following the DKA in order to better understand blood glucose control during DKA. This is an optional part of the study.
Study NCT03107208 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitor (Abbott FreeStyle Libre Pro)
Description: All participants will be asked to wear a continuous glucose monitor (CGM) during the DKA and for a week following the DKA in order to better understand blood glucose control during DKA. This is an optional part of the study.
Study NCT01472822 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Omija extract.
Description: Omija extract 1.2g/day for 12weeks
Study NCT01472822 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo 1.2g/day for 12weeks
Study NCT02426008 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Growth Factors and Cytokine adding to embryo culture media
Study NCT02426008 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: No Intervention
Description: Nothing to Add
Study NCT01280526 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Romidepsin and CHOP
Description: Romidepsin dose administered IV at day 1 and 8 or at day 1 without day 8 in combination with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) administered every 3 weeks for 8 cycles in patients with T-cell lymphoma
Study NCT02371902 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: MODULITH® SLK, STORZ MEDICAL AG, Switzerland
Description: Three sessions were carried out, with the time interval between sessions spanning between 48 and 72 hours. In each session, 2400 pulses were administered with energy flux density (EDF) ranging from 0.14 and 0.20 mJ/mm2, depending on the maximum tolerated pain of each patient. Analgesics or local anaesthetics were not administered before, during or after treatment.
Study NCT02371902 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cryoultrasound™, Medisport S.r.l., Italy
Description: Cryo-US therapy was performed in a continuous emission modality, using an ultrasound emission power rating of 1,8 Watt/cm2, and a temperature of -2˚C, for a total of 12 sessions lasting 20 minutes each. The treatment was performed in 3 weeks (4 daily sessions per week).
Study NCT02030964 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DFMO
Study NCT02030964 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Celecoxib
Study NCT02030964 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Study NCT02030964 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topotecan
Study NCT04031326 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LENA Home
Description: LENA Home is a 13-week curriculum designed to add an early-language focus to existing home visiting or parent education programs for children ages birth to three. It employs LENA wearable audio recorder technology and targeted content to help parents and other caregivers increase interactive talk. There are 13 weekly one-on-one sessions, including modules on parent-child reading and increasing verbal interaction during typical home activities. Sessions include videos, practical techniques, and feedback from LENA recordings via intuitive reports to help parents talk more with their children. LENA Home reports provide data on adult words spoken to the child (AWC) and conversational turns (CTC). LENA Home has been shown to increase interactive talk and child language ability and informs parents how much they are talking with their children in an objective way.
Study NCT02812082 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: web-based patient education
Study NCT02812082 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: questionnaire
Study NCT01727817 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Diabetes Assistant (DiAs)
Description: A medical platform that uses a smart-phone to connect to a continuous glucose sensor to insulin pump and run closed-loop control. The cell phone runs the Control to Range and is connected to work with the insulin pump and continuous glucose monitor to help keep the blood sugar in a desired range (80-180 mg/dL during the day) and help avoid hypoglycemia during the night.
Study NCT03626701 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RES (Regenerative Epidermal Suspension) prepared using the RECELL® Autologous Cell Harvesting Device
Description: Application of RES prepared using the RECELL® Autologous Cell Harvesting Device along with Telfa™ Clear primary and Xeroform™ secondary wound dressings.
Study NCT03626701 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Mepilex® Ag Wound Dressing
Description: Application of Mepilex® Ag Wound Dressing
Study NCT03626701 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional autografting (only when indicated)
Description: When indicated, conventional autografting in accordance with Investigator's standard practice
Study NCT03626701 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Conventional autografting (only when indicated)
Description: When indicated, conventional autografting in accordance with Investigator's standard practice
Study NCT00868647 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Radiofrequency ablation (RFA)
Description: Radiofrequency tumor ablation (RFA) is an imaging guided percutaneous or intra-operative procedure that uses a probe on the end of a sharp needle that is inserted directly into the tumor. The tumor is ablated by heating the probe (using electrical current alternating at radio frequency) which raises the temperature of the tumor potentially causing irreversible cell death.
Study NCT03541148 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Oncoxin-Viusid
Description: Oncoxin-Viusid supplement before/during/after standard surgical and adjuvant treatment or chemotherapy.
Study NCT03704831 — intervention group
Intervention type: OTHER
Intervention: Injection of local anesthetics during total knee arthroplasty by a locoregional anesthesia named IPACK block
Description: Injection of local anesthetics during total knee arthroplasty by a locoregional anesthesia named IPACK block (Interspace between the Popliteal Artery and the Capsule of the posterior Knee)
Study NCT03704831 — intervention group
Intervention type: OTHER
Intervention: Injection of local anesthetics during total knee arthroplasty by surgical infiltration
Description: Injection of local anesthetics during total knee arthroplasty by surgical infiltration.
Study NCT03665662 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music
Description: Intra-procedure music through headphones
Study NCT02732392 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: standard lymphadenectomy
Study NCT02732392 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: lymphadenectomy radio-isotope method
Study NCT02932800 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Fixation with ballerina technique and flip
Study NCT02932800 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Habitual Fixation
Description: Evaluation on the third and fift days, filogisticos and infectious signs, fixing loss, and culture
Study NCT02932800 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Evaluation on the third and fift days, filogisticos and infectious signs, fixing loss, and culture
Study NCT02764476 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Embodied Virtual Reality Therapy
Description: Participants will be asked to play a game in Stanford's Virtual Reality Human Interaction Lab that engages visual pathways and involves body tracking and controlled sensory feedback reinforcing movement in real and virtual time by immersive head mounted displays. This game will have subjects fully embody and inhabit an avatar from an egocentric perspective. In addition, over consecutive sessions subjects will be asked to use a mobile smart phone based virtual reality program designed to deliver various and customized emotionally provocative stimuli.
Study NCT02764476 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Virtual reality
Description: Participants will be asked to play a game in Stanford's Virtual Reality Human Interaction Lab that engages visual pathways.
Study NCT03126786 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: IVT aflibercept
Description: IVT aflibercept \[2 mg/0.05 mL\]
Study NCT03126786 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: IVT aflibercept
Description: IVT aflibercept \[2 mg/0.05 mL\]
Study NCT03126786 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Sham SC
Description: sham SC
Study NCT03126786 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SC CLS-TA
Description: CLS-TA \[4 mg/100 μL\] SC injection
Study NCT02903810 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Mixed CAR-T Transfer
Description: All subjects will be infused with αCD19-TCRz-41BB and αCD22-TCRz-41BB CAR-T cells in equal number
Study NCT01601496 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: FUSION Vascular Graft
Description: All subjects who received the FUSION Vascular Graft at the baseline implant procedure.
Study NCT04680247 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: VA-LCP
Description: Surgery using the VA-LCP implant
Study NCT04680247 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: NCB-PT
Description: Surgery using the NCB-PT implant
Study NCT03489980 — intervention group
Intervention type: OTHER
Intervention: coloring-type artistic task of a complex form
Description: coloring-type artistic task of a complex form
Study NCT01439984 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clomipramine
Description: Clomipramine 15 mg tablet or placebo tablet on demand for 12 weeks
Study NCT01439984 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Clomipramine
Description: Clomipramine 15 mg tablet or placebo tablet on demand for 12 weeks
Study NCT04649086 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rehabilitation by Eccentric exercises
Description: Participants will perform 24 exercises sessions (30 minutes) with cycloergometer in eccentric mode (while resisting against self-paced pedaling), inducing a greater muscular hypertrophy as compared with concentric mode, the mechanical stimulation being 3 to 4 times greater at the same level metabolic stimulation.
Study NCT04649086 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Rehabilitation by Concentric exercises
Description: The control group (concentric) will perform exercise training at an intensity of 60% of the reserve heart rate determined during an initial cardiorespiratory test. The power will be adjusted weekly to stay within the target heart rate range.
Study NCT03138577 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Ultrasound Imaging
Description: M-mode tracings of right diaphragm motion will be made and recorded by a skilled anesthesiologist. Patients will be examined in the supine position and scanned from a low intercostal or subcostal approach using the liver as an acoustic window. Patients will be asked to perform a voluntary sniff (VS) test, for which they will be asked to forcefully inhale through the nose in a sniffing position. The above measurement will be performed immediately preceding the brachial plexus blockade, and then at 15 minute and 30 minutes after block.
Study NCT03138577 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Supraclavicular Block
Description: The patient will be positioned supine with the head turned to the contralateral side. The ultrasound will be placed in the supraclavicular fossa, and the skin and subcutaneous tissues will be infiltrated lateral to the probe with 2% lidocaine. The anesthesiologist can redirect the needle and perform additional injections for complete coverage of the brachial plexus. The local anesthetic will be a 2:1 mix of 1.5% mepivacaine and 0.5% bupivacaine.
Study NCT03138577 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Bedside Negative Inspiratory Force Meter
Description: A bedside negative inspiratory force (NIF) meter will be used to measure negative inspiratory force prior to the block and 30 minutes after the block.
Study NCT01155622 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endovascular Cooling
Description: Infusion of \<8°C cold saline followed by the implantation of the Icy 9.3F 38-cm catheter (ZOLL Medical Corporation, Chelmsford, MA) placed in the inferior vena cava through a femoral vein connected to the Thermogard XP Temperature Management System (ZOLL Medical Corporation). Cooling was set at a maximum rate with a target temperature of 32°C or 34°C according to randomization.
Study NCT02504320 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Febuxostat XR 80 mg Capsule F1
Description: Febuxostat extended-release (XR) capsules formulation 1
Study NCT02504320 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Febuxostat XR 80 mg Capsule F2
Description: Febuxostat XR capsules formulation 2
Study NCT02504320 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Febuxostat XR 80 mg Capsule F3
Description: Febuxostat XR capsules formulation 3
Study NCT02504320 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Febuxostat XR 80 mg Capsule F4
Description: Febuxostat XR capsules formulation 4